BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4109748)

  • 1. Inheritance of malignant hyperpyrexia.
    King JO; Denborough MA; Zapf PW
    Lancet; 1972 Feb; 1(7746):365-70. PubMed ID: 4109748
    [No Abstract]   [Full Text] [Related]  

  • 2. A case report of Andersen-Tawil syndrome misdiagnosed with myodystrophy.
    Zhao X; Zu H; Yao K
    Front Neurol; 2023; 14():1170693. PubMed ID: 37456645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ring fibers visualized by electron microscopy in a Japanese patient with malignant hyperthermia.
    Kitagawa Y; Sato J; Kuriyama M; Sano K; Hashimoto K
    Odontology; 2011 Jan; 99(1):101-104. PubMed ID: 21271335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suxamethonium-induced jaw stiffness and myalgia associated with atypical cholinesterase: case report.
    Melvoll R; Stovner J; Whittaker M
    Can Anaesth Soc J; 1980 May; 27(3):283-5. PubMed ID: 7378868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strabismus as a possible sign of subclinical muscular dystrophy predisposing to rhabdomyolysis and myoglobinuria: a study of an affected family.
    Lewandowski KB
    Can Anaesth Soc J; 1982 Jul; 29(4):372-6. PubMed ID: 7104807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases.
    Flewellen EH; Nelson TE
    Can Anaesth Soc J; 1982 Jan; 29(1):42-9. PubMed ID: 7055743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hyperpyrexia and Duchenne muscular dystrophy: A case report.
    Oka S; Igarashi Y; Takagi A; Nishida M; Sato K; Nakada K; Ikeda K
    Can Anaesth Soc J; 1982 Nov; 29(6):627-9. PubMed ID: 6215975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of drugs on muscle.
    Mastaglia FL
    Drugs; 1982 Oct; 24(4):304-21. PubMed ID: 6128217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for malignant hyperpyrexia.
    Bradley WG; Murchison D
    Br Med J; 1972 Oct; 4(5832):108-9. PubMed ID: 5077443
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for malignant hyperpyrexia.
    Ellis FR; Keaney NP; Harriman DG; Sumner DW; Kyei-Mensah K; Tyrrell JH; Hargreaves JB; Parikh RK; Mulrooney PL
    Br Med J; 1972 Sep; 3(5826):559-61. PubMed ID: 5069639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of susceptibility to malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):245-7. PubMed ID: 4827071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia: an investigation of five patients.
    Britt BA; Kalow W; Gordon A; Humphrey JG; Rewcastle NB
    Can Anaesth Soc J; 1973 Jul; 20(4):431-67. PubMed ID: 4718353
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant hyperpyrexia. Further muscle studies in asymptomatic carriers identified by creatinine phosphokinase screening.
    Isaacs H; Barlow MB
    J Neurol Neurosurg Psychiatry; 1973 Apr; 36(2):228-43. PubMed ID: 4708457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hyperpyrexia.
    Bradley WG
    Br Med J; 1973 May; 2(5862):366. PubMed ID: 4704526
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical, electrophysiological and pathological studies on malignant hyperpyrexia.
    Bradley WG; Ward M; Murchison D; Hall L; Woolf N
    Proc R Soc Med; 1973 Jan; 66(1 Pt 1):67-8. PubMed ID: 4690062
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathology of malignant hyperpyrexia.
    Br Med J; 1973 Feb; 1(5848):249. PubMed ID: 4685313
    [No Abstract]   [Full Text] [Related]  

  • 18. Procaine in malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1972 Dec; 4(5839):526-8. PubMed ID: 4642792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.
    Britt BA
    Anesth Prog; 1974; 21(4):108-10. PubMed ID: 4527005
    [No Abstract]   [Full Text] [Related]  

  • 20. Central-core disease and malignant hyperpyrexia.
    Denborough MA; Dennett X; Anderson RM
    Br Med J; 1973 Feb; 1(5848):272-3. PubMed ID: 4265427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.